D.E. Shaw & Co
AGIO icon

D.E. Shaw & Co’s Agios Pharmaceuticals AGIO Stock Holding History

D.E. Shaw & Co’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,100
Closed -$656K – 4490
2025
Q4 		$656K Buy
+24,100
New +$846K ﹤0.01% 3792
2018
Q4 		– Sell
-12,000
Closed -$925K – 3727
2018
Q3 		$925K Hold
12,000
– – ﹤0.01% 2738
2018
Q2 		$1.01M Buy
+12,000
New +$1.05M ﹤0.01% 2696
2015
Q2 		– Sell
-10,000
Closed -$943K – 3724
2015
Q1 		$943K Hold
10,000
– – ﹤0.01% 2599
2014
Q4 		$1.12M Buy
+10,000
New +$893K ﹤0.01% 2745

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

D.E. Shaw & Co's AGIO Position: Q1 2026 in Review

D.E. Shaw & Co increased its Agios Pharmaceuticals (AGIO) stake by 46% in Q1 2026, buying an estimated $23.9M and bringing the position to 2,681,169 shares worth $90.7M. The position accounts for 0.05% of the portfolio, ranked #415.

D.E. Shaw & Co first reported a position in AGIO in Q2 2014 and has held it in 40 quarters since. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • D.E. Shaw & Co held 2,681,169 shares of Agios Pharmaceuticals worth $90.7M as of Q1 2026.
  • D.E. Shaw & Co bought 843,983 Agios Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
  • Agios Pharmaceuticals made up 0.05% of D.E. Shaw & Co's portfolio in Q1 2026, its #415 holding.
  • D.E. Shaw & Co first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 40 quarters since.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.